Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Novocure

< Previous 1 2 3 4 Next >
Novocure to Report First Quarter 2022 Financial Results
From Novocure
Via Business Wire
Tickers NVCR
Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian Cancer
From Novocure
Via Business Wire
Tickers NVCR
Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation
From Novocure
Via Business Wire
Tickers NVCR
Novocure’s General Counsel Resigns After 10 Years of Service
From Novocure
Via Business Wire
Tickers NVCR
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
From Novocure
Via Business Wire
Tickers NVCR
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
From Novocure
Via Business Wire
Tickers NVCR
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
From Novocure
Via Business Wire
Tickers NVCR
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New Hampshire
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
From Novocure
Via Business Wire
Tickers NVCR
Novocure to Participate in Two Upcoming Investor Conferences
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
From Novocure
Via Business Wire
Tickers NVCR
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces 31 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2021 Annual Meeting
From Novocure
Via Business Wire
Tickers NVCR
Novocure Reports Third Quarter 2021 Financial Results and Provides Company Update
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian Cancer
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual Meeting
From Novocure
Via Business Wire
Tickers NVCR
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
From Novocure
Via Business Wire
Tickers NVCR
Novocure to Report Third Quarter 2021 Financial Results
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer
From Novocure
Via Business Wire
Tickers NVCR
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
From Novocure
Via Business Wire
Tickers NVCR
Novocure to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
From Novocure
Via Business Wire
Tickers NVCR
Novocure Appoints Bill Burke as Chief Human Resources Officer
From Novocure
Via Business Wire
Tickers NVCR
Novocure Reports Second Quarter 2021 Financial Results and Provides Company Update
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
From Novocure
Via Business Wire
Tickers NVCR
Novocure to Report Second Quarter 2021 Financial Results
From Novocure
Via Business Wire
Tickers NVCR
Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer
From Novocure
Via Business Wire
Tickers NVCR
Novocure Initiates Usability Study for Flexible Torso Array
From Novocure
Via Business Wire
Tickers NVCR
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
From Novocure
Via Business Wire
Tickers NVCR
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.